SIMPLEX TRADING, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 3 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,199
+65.2%
74,300
+324.6%
0.00%0.0%
Q2 2023$726
-86.2%
17,500
-80.0%
0.00%
-80.0%
Q1 2023$5,268
+15.9%
87,600
+41.3%
0.01%0.0%
Q4 2022$4,547
-99.8%
62,000
+69.9%
0.01%
+66.7%
Q3 2022$2,773,000
+128.0%
36,500
+108.6%
0.00%
+200.0%
Q2 2022$1,216,000
-67.7%
17,500
-61.5%
0.00%
-66.7%
Q1 2022$3,761,000
+14.4%
45,400
+3.7%
0.00%0.0%
Q4 2021$3,288,000
+62.0%
43,800
+309.3%
0.00%
+50.0%
Q3 2021$2,030,000
-9.4%
10,700
+5.9%
0.00%0.0%
Q2 2021$2,240,000
+173.5%
10,100
+16190.3%
0.00%
+100.0%
Q1 2021$819,000
-92.1%
62
-89.6%
0.00%
-92.3%
Q4 2020$10,330,000
+12.0%
597
-28.0%
0.01%0.0%
Q3 2020$9,227,000
+161.1%
829
+39.1%
0.01%
+116.7%
Q2 2020$3,534,000
-55.4%
596
-49.4%
0.01%
-57.1%
Q1 2020$7,932,000
+25.8%
1,178
+57.5%
0.01%0.0%
Q4 2019$6,303,000
+103.1%
748
+80.2%
0.01%
+55.6%
Q3 2019$3,103,000
+188.9%
415
+144.1%
0.01%
+200.0%
Q2 2019$1,074,000
+1391.7%
170
+1033.3%
0.00%
Q1 2019$72,000
-72.0%
15
-80.5%
0.00%
-100.0%
Q4 2018$257,000
-46.0%
77
-15.4%
0.00%
-50.0%
Q3 2018$476,000
+15766.7%
91
+9000.0%
0.00%
Q2 2018$3,000
+50.0%
1
-96.9%
0.00%
Q1 2018$2,000
-50.0%
32
-36.0%
0.00%
Q4 2017$4,000
-33.3%
50
+61.3%
0.00%
Q3 2017$6,000
-33.3%
31
-74.6%
0.00%
Q2 2017$9,000122
+269.7%
0.00%
Q1 2017$033
+1550.0%
0.00%
Q4 2016$0
-100.0%
2
-99.1%
0.00%
Q3 2016$6,000
-84.6%
234
+134.0%
0.00%
-100.0%
Q2 2016$39,000
+387.5%
100
+809.1%
0.00%
+200.0%
Q1 2016$8,000
+700.0%
11
+10.0%
0.00%
Q4 2015$1,000100.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2020
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 93,800$7,043,0000.26%
GROUP ONE TRADING, L.P. 115,900$8,702,0000.01%
HBK INVESTMENTS L P 18,000$1,351,0000.01%
SIMPLEX TRADING, LLC 43,800$3,288,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NOVOCURE LTD shareholders